NO20013397D0 - Anvendelse av apoptose-induserende midler ved behandling av (auto)immune sykdommer - Google Patents
Anvendelse av apoptose-induserende midler ved behandling av (auto)immune sykdommerInfo
- Publication number
- NO20013397D0 NO20013397D0 NO20013397A NO20013397A NO20013397D0 NO 20013397 D0 NO20013397 D0 NO 20013397D0 NO 20013397 A NO20013397 A NO 20013397A NO 20013397 A NO20013397 A NO 20013397A NO 20013397 D0 NO20013397 D0 NO 20013397D0
- Authority
- NO
- Norway
- Prior art keywords
- auto
- apoptosis
- treatment
- immune disorders
- inducing agents
- Prior art date
Links
- 208000026278 immune system disease Diseases 0.000 title abstract 3
- 230000006907 apoptotic process Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 abstract 1
- 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 abstract 1
- 230000001640 apoptogenic effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000001476 gene delivery Methods 0.000 abstract 1
- 230000006882 induction of apoptosis Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 210000002437 synoviocyte Anatomy 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99200056 | 1999-01-11 | ||
PCT/NL2000/000013 WO2000041497A2 (en) | 1999-01-11 | 2000-01-10 | Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013397D0 true NO20013397D0 (no) | 2001-07-09 |
NO20013397L NO20013397L (no) | 2001-09-11 |
Family
ID=8239795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013397A NO20013397L (no) | 1999-01-11 | 2001-07-09 | Anvendelse av apoptose-induserende midler ved behandling av (auto)immune sykdommer |
Country Status (18)
Country | Link |
---|---|
US (1) | US20050271624A1 (no) |
EP (1) | EP1143994B1 (no) |
JP (1) | JP2003500336A (no) |
AT (1) | ATE244014T1 (no) |
AU (1) | AU3083500A (no) |
CA (1) | CA2359392A1 (no) |
DE (1) | DE60003632T2 (no) |
DK (1) | DK1143994T3 (no) |
EA (1) | EA200100770A1 (no) |
ES (1) | ES2202039T3 (no) |
HU (1) | HUP0200552A2 (no) |
IL (2) | IL144228A0 (no) |
MX (1) | MXPA01006998A (no) |
NO (1) | NO20013397L (no) |
PT (1) | PT1143994E (no) |
TR (1) | TR200102713T2 (no) |
WO (1) | WO2000041497A2 (no) |
ZA (1) | ZA200105632B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1377667B1 (en) * | 2001-03-30 | 2008-11-19 | Leadd B.V. | Fusion proteins for specific treatment of cancer and auto-immune diseases |
DK1390403T3 (da) * | 2001-05-25 | 2007-05-14 | Nymox Corp | Peptider afledt af nervetrådsproteiner og medicinsk anvendelse deraf |
DK1417228T3 (da) * | 2001-07-19 | 2007-06-04 | Nymox Corp | Peptider der er effektive til behandling af tumorer og andre tilstande som kræver fjernelse eller destruktion af celler |
US7317077B2 (en) * | 2001-11-16 | 2008-01-08 | Nymox Pharmaceutical Corporation | Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670488A (en) * | 1992-12-03 | 1997-09-23 | Genzyme Corporation | Adenovirus vector for gene therapy |
US5981502A (en) * | 1990-09-12 | 1999-11-09 | Leadd B.V. | Methods and compositions for inducing apoptosis in tumor cells |
EP0878546A1 (en) * | 1997-04-15 | 1998-11-18 | Leadd B.V. | A gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin |
US5792751A (en) * | 1992-04-13 | 1998-08-11 | Baylor College Of Medicine | Tranformation of cells associated with fluid spaces |
EP0830604B1 (en) * | 1995-06-07 | 2003-05-28 | Leadd B.V. | Uses of apoptin |
WO1997029201A2 (de) * | 1996-02-07 | 1997-08-14 | Max-Delbrück-Centrum für Molekulare Medizin | Retroviraler vektor für den gentransfer eines il6-antagonisten in humane hämatopoetische stammzellen |
PL191586B1 (pl) * | 1997-02-28 | 2006-06-30 | Boehringer Ingelheim Pharma | Gen chimeryczny, środek farmaceutyczny go zawierający, zastosowanie genu chimerycznego oraz sposób konstruowania genu chimerycznego |
JPH10324699A (ja) * | 1997-03-21 | 1998-12-08 | Sankyo Co Ltd | 抗ヒトFasヒト化抗体 |
IL123756A0 (en) * | 1997-03-21 | 1998-10-30 | Sankyo Co | Humanized anti-human FAS antibody |
-
2000
- 2000-01-10 AT AT00900970T patent/ATE244014T1/de not_active IP Right Cessation
- 2000-01-10 WO PCT/NL2000/000013 patent/WO2000041497A2/en active IP Right Grant
- 2000-01-10 DE DE60003632T patent/DE60003632T2/de not_active Expired - Fee Related
- 2000-01-10 AU AU30835/00A patent/AU3083500A/en not_active Abandoned
- 2000-01-10 ES ES00900970T patent/ES2202039T3/es not_active Expired - Lifetime
- 2000-01-10 JP JP2000593120A patent/JP2003500336A/ja active Pending
- 2000-01-10 IL IL14422800A patent/IL144228A0/xx unknown
- 2000-01-10 TR TR2001/02713T patent/TR200102713T2/xx unknown
- 2000-01-10 MX MXPA01006998A patent/MXPA01006998A/es unknown
- 2000-01-10 CA CA002359392A patent/CA2359392A1/en not_active Abandoned
- 2000-01-10 EP EP20000900970 patent/EP1143994B1/en not_active Expired - Lifetime
- 2000-01-10 PT PT00900970T patent/PT1143994E/pt unknown
- 2000-01-10 DK DK00900970T patent/DK1143994T3/da active
- 2000-01-10 HU HU0200552A patent/HUP0200552A2/hu unknown
- 2000-01-10 EA EA200100770A patent/EA200100770A1/ru unknown
-
2001
- 2001-07-09 NO NO20013397A patent/NO20013397L/no not_active Application Discontinuation
- 2001-07-09 ZA ZA200105632A patent/ZA200105632B/en unknown
- 2001-07-10 IL IL144228A patent/IL144228A/en not_active IP Right Cessation
-
2005
- 2005-02-25 US US11/067,001 patent/US20050271624A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP0200552A2 (en) | 2002-06-29 |
EP1143994B1 (en) | 2003-07-02 |
TR200102713T2 (tr) | 2002-05-21 |
ATE244014T1 (de) | 2003-07-15 |
EP1143994A2 (en) | 2001-10-17 |
ZA200105632B (en) | 2002-10-09 |
EA200100770A1 (ru) | 2002-02-28 |
DE60003632T2 (de) | 2004-04-15 |
CA2359392A1 (en) | 2000-07-20 |
DE60003632D1 (de) | 2003-08-07 |
NO20013397L (no) | 2001-09-11 |
IL144228A (en) | 2009-06-15 |
ES2202039T3 (es) | 2004-04-01 |
PT1143994E (pt) | 2003-11-28 |
JP2003500336A (ja) | 2003-01-07 |
AU3083500A (en) | 2000-08-01 |
IL144228A0 (en) | 2002-05-23 |
WO2000041497A3 (en) | 2000-09-28 |
WO2000041497A2 (en) | 2000-07-20 |
DK1143994T3 (da) | 2003-10-20 |
US20050271624A1 (en) | 2005-12-08 |
MXPA01006998A (es) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN08064A1 (en) | Albumin fusion proteins | |
AU2002258808A1 (en) | Humanized antibodies | |
WO2005077042A3 (en) | Albumin fusion proteins | |
WO2007067730A3 (en) | Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use | |
WO2003060071A3 (en) | Albumin fusion proteins | |
MX2009002816A (es) | Proteinas de fusion de albumina. | |
WO2001079443A3 (en) | Albumin fusion proteins | |
HUP0300369A2 (hu) | Többértékű antitestek és alkalmazásuk | |
ATE403680T1 (de) | Herstellung tetravalenter antikörper | |
NZ502527A (en) | Catalytic monoclonal antibodies raised to proteins in aggregated form, and use to treat alzheimers, atherosclerosis, amyloidosis and prions disease | |
FI963101A (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
EP1385544A4 (en) | HUMANIZED ANTIBODIES | |
WO2002018620A3 (en) | Neutrokine-alpha and neutrokine-alpha splice variant | |
WO2003033658A3 (en) | Neutrokine-alpha and neutrokine-alpha splice variant | |
WO2001098491A3 (en) | Osteolevin gene polymorphisms | |
WO1999028460A3 (en) | Molecules interacting with apoptin | |
WO2004099388A3 (en) | Cbl-b polypeptides, complexes and related methods | |
NO20013397L (no) | Anvendelse av apoptose-induserende midler ved behandling av (auto)immune sykdommer | |
IL154298A0 (en) | Papap proteins, their preparation and use | |
MXPA03010728A (es) | Moleculas de proteina-2 relacionadas con b7 y uso de las mismas. | |
EP1161262A4 (en) | COLLIGIN / HsP47 WITH SURFACE LOCATION IN CARCINOMA CELLS | |
EP1475441A3 (fr) | Acides nucléiques et polypeptides spécifiques des souches pathogènes du genre Neisseria | |
WO2002072632A3 (en) | Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. | |
WO2001018037A3 (en) | A p53-induced protein with a death domain that can promote apoptosis | |
WO2001061010A3 (en) | GTPASE activating proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |